Amerikanische Gesellschaft für Hirudotherapie

ERGA-BGE reference genome of a once neglected freshwater haematophagous European medicinal leech

Genome resource published in Open Res Eur (2026)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomik & ProteomikSpeichel-PharmakologieManzano-Marin A et al. · Open research Europe, 2026

Abstract

Hirudo verbana Carena, 1820, commonly known as the southern medicinal leech, is one of several European medicinal leeches, whose full diversity has just recently started to be uncovered. Historically, it has been widely used as a medicinal leech and for centuries it was treated erroneously under the specific name of Hirudo medicinalis L. 1758. Recent molecular and taxonomic analyses have revealed subspecific diversity within the morphospecies H. verbana. Hirudo verbana is a blood-feeding species sucking blood from amphibians, fish, and mammals. It occupies freshwater habitats, typically shallow ponds and lakes. Studies show that this leech species has a "naturally limited microbiome", suggesting it may serve as a powerful model system for the study of gut microbiota. We expect this chromosome-level assembly of H. verbana to serve as a high-quality genomic resource for this most famous leech genus and to serve as a foundation to the study of the diversification and biodiversity of European medicinal leeches, as well as their gut-associated symbionts. The genome of H. verbana was assembled into two haplotypes through a phased assembly approach; however, only the primary haplotype was designated as the reference genome for annotation and downstream analyses. The entirety of the primary haplotype was assembled into 14 contiguous chromosomal pseudomolecules, including the mitogenome. This chromosome-level assembly encompasses 0.18 Gb, composed of 277 contigs and 27 scaffolds, with contig and scaffold N50 values of 1.3 Mb and 13.4 Mb, respectively.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Chromosome-level reference genome assembly for the Southern medicinal leech (Hirudo verbana subspecies) produced by the European Reference Genome Atlas / Biodiversity Genomics Europe project. 0.18 Gb, 14 chromosomal pseudomolecules including mitogenome. Supports gut-microbiome and species-diversity research.

Warum dies für die Hirudotherapie relevant ist

This paper reports a chromosome-level reference genome assembly of Hirudo verbana, the southern medicinal leech, assembled into 14 contiguous chromosomal pseudomolecules encompassing 0.18 Gb with contig and scaffold N50 values of 1.3 Mb and 13.4 Mb, respectively, generated through a phased assembly approach. For ASH's domain, this is relevant as a foundational genomic resource for a historically important medicinal leech species; the abstract states it is expected to serve as a foundation for studying the diversification and biodiversity of European medicinal leeches as well as their gut-associated symbionts, and notes H. verbana has a naturally limited microbiome that may make it a powerful model for gut microbiota research. However, this is a genome announcement without functional or clinical data, and its therapeutic relevance is indirect and prospective.

Zitation

ERGA-BGE reference genome of a once neglected freshwater haematophagous European medicinal leech.

Manzano-Marin A et al. · Open research Europe, 2026

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.